NNSA Mo-99 Stakeholders Meeting

November 3-4, 2021

The 2021 NNSA Mo-99 Stakeholders Meeting was held via Zoom video conference on Wednesday, November 3 and Thursday, November 4, 2021, from 12:30 to 4:00 pm Eastern time.

View PDF Agenda

Day One: Wednesday, November 3
12:30 pm Welcome and Introductions Joanie Dix, National Nuclear Security Administration, Office of Conversion
12:45 pm U.S. Government Mo-99 Program Updates

Max Postman, National Nuclear Security Administration
Steven Lynch, Nuclear Regulatory Commission (View PDF)
Danae Christodoulou, Food and Drug Administration (View PDF)

1:45 pm Break  
2:00 pm Mo-99 Producer Updates Eric Schutt, Rachel Houseman, and Tracy Radel, SHINE Medical Technologies
Jim Harvey, NorthStar Medical Radioisotopes
Terry Grimm and Mike Zamiara, Niowave
Erik Nygaard, BWX Technologies
3:45 pm Adjourn Max Postman, National Nuclear Security Administration
Day Two: Thursday, November 4
12:30 pm U.S. Mo-99 Supply Status — Industry Perspectives Roy Brown, Curium Pharma
David Pelliciarini, Cardinal Health
John Witkowski, United Pharmacy Partners (UPPI) (View PDF)
Leah Gannon, Vizient
Ira Goldman, Lantheus / Nuclear Medicine Europe Security of Supply Working Group
2:15 pm Break  
2:30 pm Open Discussion of Mo-99 International Symposium Max Postman, National Nuclear Security Administration
3:00 pm Open Floor for General Stakeholder Comments/ Remarks Max Postman, National Nuclear Security Administration
3:30 pm Closing Remarks/Adjourn Joanie Dix, National Nuclear Security Administration

Questions?

Please address inquiries to:
Dr. John W. Holland
Argonne National Laboratory
Phone: +1 (630) 252-3079
Email: [email protected]

HOST

NNSA logo

 

HOST: NNSA logo